Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The poliovirus capsid is the protein shell that encases the viral RNA genome. It is a highly structured, icosahedral assembly composed of four distinct viral proteins: VP1, VP2, VP3, and VP4. The capsid mediates attachment to the host cell receptor CD155/PVR, facilitates entry and uncoating, and protects the viral genome. VP1 interacts directly with the host receptor CD155/PVR. VP4 is located on the inner face of the capsid and is released during uncoating to facilitate genome release into host cells. Assembly proceeds via pentameric intermediates containing immature forms like myristoyl-VP0 before final cleavage yields mature virions.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poliovirus Capsid Protein (N/A).